next up previous index Surgical Topics
Next: Index Up: Systemic Inflammatory Response Syndrome Previous: Activated Protein C and   Index


American College of Chest Physicians-Society of Critical Care Medicine Consensus Conference.
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.
Crit Care Med, 20:864-75, 1992.

T. G. Buchman.
file:/home/adrian/documents/texstuff/bibs/papers/1994/buchman1994/buchman1994.dvi Manipulation of stress gene expression: A novel therapy for the treatment of sepsis.
Crit Care Med, 22(6):901-3, June 1994.

J. F. Dhainaut, P. F. Laterre, J. M. Janes, G. R. Bernard, A. Artigas, J. Bakker, H. Riess, B. R. Basson, J. Charpentier, B. G. Utterback, J. L. Vincent, and Recombinant Human Activated Protein C Worldwide Evaluation in Sepsis (PROWESS) Study Group.
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.
Intensive Care Med, 29(6):894-903, June 2003.

M. S. Rangel-Frausto, D. Pettet, M. Costigan, T. Hwang, C. S. Davis, and R. P. Wenzel.
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.
JAMA, 273:117-23, 1995.

Adrian P. Ireland